Mesoblast Ltd has released a press release.
Ryoncil Commercial Launch Update and Product Pipeline
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Mesoblast
- Mesoblast raises new capital for ryoncil commercial launch
- Trading Halt
- Pause in Trading
- FDA Approves Mesoblast Ryoncil
- Material Announcement
Later from Mesoblast
- Dr. Gregory George MD PhD Joins Mesoblast Board
- Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter
- Ryoncil Pricing Set and Available This Quarter
- Arcadium Lithium PLC to be removed from the S&P/ASX 200
- Mesoblast Added to S&P/ASX 200 INDEX
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast